Expression and activity levels of matrix metalloproteinase-7
and in situ localization of caseinolytic activity in colorectal cancer.
Matrix metalloproteinase-7 mediated cleveage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and Metastasis.
Kanetake, "Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis," Clinical Cancer Research, vol.
Jung, "Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinoma," Cancer Science, vol.
Liaw, "Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7
(matrilysin)," Journal of Biological Chemistry, vol.
Matrilysin (matrix metalloproteinase-7
) selects for apoptosis-resistant mammary cells in vivo.
activates MMP-8 but not MMP-13.
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
(MMP-7), a zinc- and calcium-dependent endopeptidase, is 1 of these 12 candidate proteins.
A multiplexed particle-based flow cytometric assay identified plasma matrix metalloproteinase-7
to be associated with cancer-related death among patients with bladder cancer.